%0 Journal Article %T A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401) %A Okajima, Masaaki %A Miura, Satoru %A Watanabe, Satoshi %A Tanaka, Hiroshi %A Ito, Kazuhiko %A Ishida, Takashi %A Makino, Masato %A Iwashima, Akira %A Matsumoto, Naoya %A Sato, Kazuhiro %A Ichikawa, Kosuke %A Abe, Tetsuya %A Yoshizawa, Hirohisa %A Kikuchi, Toshiaki %J Translational Lung Cancer Research %D 2020 %B 2020 %9 %! A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401) %K %X %U https://tlcr.amegroups.org/article/view/47019 %V 10 %N 1 %P 252-260 %@ 2226-4477